Modulation of expression of RA-regulated genes by the oncoprotein v-erbA

Gene

Volumn 425, Issue 1-2, 2008, Pages 23-27

  Ventura Holman, Tereza ^a   Mamoon, Abulkhair ^a   Subauste, Jose S ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b G V SONNY MONTGOMERY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dominant negative; Hepatocellular carcinoma; Microarray; Nuclear receptors; Retinoic acid receptor (RAR)

Indexed keywords

CELL NUCLEUS RECEPTOR; ONCOPROTEIN; ONCOPROTEIN V ERBA; RETINOIC ACID; RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FAMILY; TRANSGENIC MOUSE; V ERBA ONCOGENE;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEPATOCYTES; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS V-ERBA; PROTEIN BIOSYNTHESIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSFECTION; TRETINOIN;

MURINAE; MUS MUSCULUS; VERTEBRATA;

EID: 53149094643     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2008.08.006     Document Type: Article

References (23)

1. Andersson M.L., and Vennstrom B. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site. Oncogene 19 (2000) 3563-3569
2. Barlow C., Meister B., Lardelli M., Lendahl U., and Vennstrom B. Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA. EMBO J. 13 (1994) 4241-4250
3. Bonamy G.M., and Allison L.A. Oncogenic conversion of the thyroid hormone receptor by altered nuclear transport. Nucl. Recept. Signal 4 (2006) e008
4. Bonamy G.M., Guiochon-Mantel A., and Allison L.A. Cancer promoted by the oncoprotein v-ErbA may be due to subcellular mislocalization of nuclear receptors. Mol. Endocrinol. 19 (2005) 1213-1230
5. Chan K.Y., et al. Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma. Mod. Pathol. 19 (2006) 1546-1554
6. Damm K., Thompson C.C., and Evans R.M. Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339 (1989) 593-597
7. Dennis Jr. G., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4 (2003) P3
8. Fernandes I., et al. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. Mol. Cell 11 (2003) 139-150
9. Hoffmann B., et al. A retinoic acid receptor-specific element controls the retinoic acid receptor-beta promoter. Mol. Endocrinol. 4 (1990) 1727-1736
10. Lee S., and Privalsky M.L. Multiple mutations contribute to repression by the v-erbA oncoprotein. Oncogene 24 (2005) 6737-6752
11. Leid M., Kastner P., and Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. Sci. 17 (1992) 427-433
12. Mader S., Chen J.Y., Chen Z., White J., Chambon P., and Gronemeyer H. The patterns of binding of RAR, RXR and TR homo- and heterodimers to direct repeats are dictated by the binding specificities of the DNA binding domains. EMBO J. 12 (1993) 5029-5041
13. Mamoon A., Ventura-Holman T., Maher J.F., and Subauste J.S. Retinoic acid responsive genes in the murine hepatocyte cell line AML 12. Gene 408 (2008) 95-103
14. Nagl S.B., Bunn C.F., and Allison L.A. v-erbA oncogene initiates ultrastructural changes characteristic of early and intermediate events of meiotic maturation in Xenopus oocytes. J. Cell Biochem. 67 (1997) 184-200
15. Ogasawara S., Yano H., Iemura A., Hisaka T., and Kojiro M. Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines. Hepatology 24 (1996) 198-205
16. Rietveld L.E., Caldenhoven E., and Stunnenberg H.G. Avian erythroleukemia: a model for corepressor function in cancer. Oncogene 20 (2001) 3100-3109
17. Selmi S., and Samuels H.H. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation. J. Biol. Chem. 266 (1991) 11589-11593
18. Shao R.X., et al. Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways. Gastroenterology 128 (2005) 86-95
19. Sharif M., and Privalsky M.L. v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action. Cell 66 (1991) 885-893
20. Subauste J.S., and Koenig R.J. Characterization of the DNA-binding and dominant negative activity of v-erbA homodimers. Mol. Endocrinol. 12 (1998) 1380-1392
21. Wands J. Hepatocellular carcinoma and sex. N. Engl. J. Med. 357 (2007) 1974-1976
22. Weston A.D., Blumberg B., and Underhill T.M. Active repression by unliganded retinoid receptors in development: less is sometimes more. J. Cell Biol. 161 (2003) 223-228
23. Zubkova I., and Subauste J.S. v-erba homodimers mediate the potent dominant negative activity of v-erba on everted repeats. Mol. Biol. Rep. 31 (2004) 131-137